Condition
Herpetic Keratitis
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06757907Not ApplicableCompletedPrimary
Topical Ganciclovir Versus Systemic Aciclovir in the Treatment of Herpetic Keratitis
NCT04420429Completed
The Effect Of Preoperative Parameters On Success After DMEK Surgery
NCT04384094Unknown
Defining the Operating Parameters for a Rebound-esthesiometer
Showing all 3 trials